Elevated estrogen receptor expression in human prostatic stromal cells by androgen ablation therapy

Journal of Urology

Volumn 156, Issue 3, 1996, Pages 1194-1197

  Kruithof Dekker, Inge G ^b   Têtu, Bernard ^b   Janssen, Patrick J A ^b   Van Der Kwast, Theodorus H ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b NONE

Author keywords

immunohistochemistry; prostate; receptors, estrogen

Indexed keywords

ESTROGEN RECEPTOR; FLUTAMIDE; GONADORELIN; GONADORELIN AGONIST;

ARTICLE; CLINICAL ARTICLE; DRUG MECHANISM; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN LOCALIZATION; RECEPTOR GENE;

EID: 0029758865     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65749-5     Document Type: Article

References (23)

1. Bainborough, A. R.: Squamous metaplasia of prostate following estrogen therapy. J. Urol., 68: 329, 1952.
2. Têtu, B., Srigley, J. R., Boivin, J.-C., Dupont, A., Monfette, G., Pinault, S. and Labrie, F.: Effect of combination endocrine therapy (LHRH agonist and flutamide) on normal prostate and prostatic adenocarcinoma. Am. J. Surg. Pathol., 15: 111, 1991.
3. Civantos, F., Marcial, M. A., Banks, E. R., Ho, C. K., Speights, D. O., Drew, P. A., Murphy, W. M. and Soloway, M. S.: Pathology of androgen deprivation therapy in prostate carcinoma. Cancer, 75: 1634, 1995.
4. Santti, R., Newbold, R. R., Makela, S., Pylkannen, L. and McLachlan, J. A.: Developmental estrogenization and prostatic neoplasia. Prostate, 24: 67, 1994.
5. Habenicht, U. F., Tunn, U. W., Senge, T., Schröder, F. H., Schweikert, H. U., Bartsch, G. and El Etreby M. F.: Management of benign prostatic hyperplasia with particular emphasis on aromatase inhibitors. J. Steroid Biochem. Mol. Biol., 44: 557, 1993.
6. Levine, A. C., Kirschenbaum, A., Droller, M. and Gabrilove, J. L.: Effect of the addition of estrogen to medical castration on prostatic size, symptoms, histology and serum prostate specific antigen in 4 men with benign prostatic hypertrophy. J. Urol., 146: 790, 1991.
7. Krongrad, A., Wilson, C. M., Wilson, J. D., Allman, D. R. and McPhaul, M. J.: Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells. Mol. Cell. Endocrinol., 76: 79, 1991.
8. West, N. B., Chang, C., Liao, S. and Brenner, R.: Localization and regulation of estrogen, progestin and androgen receptors in the seminal vesicle of the Rhesus monkey. J. Steroid Biochem. Mol. Biol., 37: 11, 1990.
9. Horwitz, K. B. and McGuire, W. L.: Nuclear mechanism of estrogen action. J. Biol. Chem., 253: 8185, 1978.
10. Bødker, A., Andersson, K.-E., Batra, S., Juhl, B. R. and Meyhoff, H. H.: The estrogen receptor expression in the male rabbit urethra and prostate following castration. Scand. J. Urol. Nephrol., 28: 113, 1994.
11. Labrie, F., Cusan, L., Gomez, J.-L., Diamond, P., Suburu, R., Lemay, M., Têtu, B., Fradet, Y. and Candas, B.: Down-staging of early stage prostate cancer before radical prostatectomy: the first randomized trial of neoadjuvant combination therapy with flutamide and a luteinizing hormone-releasing hormone agonist. Urol. Symp., 44: 29, 1994.
12. Ravn, V., Rasmussen, B. B., Hojholt, L., Barfoed, M., Heiberg, I. and Thorpe, S. M.: Reproducibility of subjective immunohistochemical estrogen- and progesterone receptor determination in human endometrium. Pathol. Res. Pract., 189: 1015, 1993.
13. Suzuki, K., Takezawa, Y., Suzuki, T., Honma, S. and Yamanaka, H.: Synergistic effect of estrogen with androgen on the prostate - effects of estrogen on the prostate of androgen-administered rats and 5-alpha-reductase activity. Prostate, 25: 169, 1994.
14. Walsh, P. C. and Wilson, J. D.: The induction of prostatic hypertrophy in the dog with androstanediol. J. Clin. Invest., 57: 1093, 1976.
15. Bartsch, G., Bruengger, A., de Klerk, P., Coffey, D. S. and Rohr, H. P.: Light-microscopic stereologic analysis of spontaneous and steroid-induced canine prostatic hyperplasia. J. Urol., 137: 552, 1987.
16. Aumüller, G., Funke, P. J., Hahn, A., Hoffbauer, G., Tunn, U. and Neumann, F.: Phenotypic modulation of the canine prostate after long-term treatment with androgens and estrogens. Prostate, 3: 361, 1982.
17. De Voogt, H. J., Rao, B. R., Geldof, A. A., Gooren, L. J. G. and Bouman, F. G.: Androgen action blockade does not result in reduction in size but changes histology of the normal human prostate. Prostate, 11: 305, 1987.
18. Wernert, N., Gerdes, J., Loy, V., Seitz, G., Scherr, O. and Dhom, G.: Investigation of the estrogen (ER-ICA-test) and the progesterone receptor in the prostate and prostate carcinoma on immunohistochemical basis. Virchows Arch. A, 412: 387, 1988.
19. Brolin, J., Skoog, L. and Ekman, P.: Immunohistochemistry and biochemistry in detection of androgen, progesterone and estrogen receptors in benign and malignant human prostatic tissue. Prostate, 20: 281, 1992.
20. Van der Kwast, T. H., Têtu, B., Fradet, Y., Dupont, A., Gomez, J., Cusan, L., Diamond, P. and Labrie, F.: Androgen receptor modulation in benign human prostatic tissue and prostatic adenocarcinoma during neoadjuvant endocrine combination therapy. Prostate, 28: 227, 1996.
21. Harman, S. M. and Tsitouras, P. D.: Reproductive hormones in aging men. I. Measurement of sex steroids, basal luteinizing hormone, and Leydig cell response to human chorionic gonadotropin. J. Clin. Endocrinol. Metab., 51: 35, 1980.
22. Nakhla, A. M., Khan, M. S., Romas, N. P. and Romas, W.: Estradiol causes the rapid accumulation of cAMP in human prostate. Proc. Natl. Acad Sci. U.S.A., 91: 5402, 1994.
23. Krieg, M., Nass, R. and Tunn, S.: Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. J. Clin. Endocrinol. Metab., 77: 375, 1993.